at the Intersection of
Opioid Use Disorder
and Infectious Disease
PROCEEDINGS OF A WORKSHOP
Anna Nicholson, Rapporteur
Board on Population Health and Public Health Practice
Health and Medicine Division
THE NATIONAL ACADEMIES PRESS
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001
This activity was supported by Contract No. 10003842 between the National Academy of Sciences and the Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-47794-9
International Standard Book Number-10: 0-309-47794-8
Digital Object Identifier: https://doi.org/10.17226/25153
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2018 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2018. Integrating responses at the intersection of opioid use disorder and infectious disease epidemics: Proceedings of a workshop. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/25153.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. C. D. Mote, Jr., is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
WORKSHOP PLANNING COMMITTEE ON INTEGRATING INFECTIOUS DISEASE CONSIDERATIONS WITH RESPONSE TO THE OPIOID EPIDEMIC1
CARLOS M. DEL RIO (Chair), Hubert Professor and Chair, Rollins School of Public Health, Emory University
JOHN DREYZEHNER, Commissioner, Tennessee Department of Health
TRACI G. GREEN, Adjunct Associate Professor of Emergency Medicine, Adjunct Associate Professor of Epidemiology, Boston Medical Center
VAN INGRAM, Executive Director, Kentucky Office of Drug Control Policy
P. TODD KORTHUIS, Associate Professor of Medicine, Program Director, Addiction Medicine Fellowship, and Chief, Addiction Medicine Section, Oregon Health & Science University
NATASHA K. MARTIN, Associate Professor, University of California, San Diego
SANDRA ANN SPRINGER, Associate Professor of Medicine, Associate Clinical Professor of Nursing, Yale School of Medicine; Director, Infectious Disease Outpatient Clinic–Newington, and Attending Physician–West Haven, Veterans Affairs Connecticut Healthcare System, Newington
DACE SVIKIS, Deputy Director, Institute for Women’s Health, Virginia Commonwealth University
CHUCK WEXLER, Executive Director, Police Executive Research Forum
Health and Medicine Division Staff
KATHLEEN STRATTON, Scholar, Study Director
HOPE HARE, Administrative Assistant
ALEXIS WOJTOWICZ, Senior Program Assistant
ROSE MARIE MARTINEZ, Senior Director, Board on Population Health and Public Health Practice
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteur and the institution.
This page intentionally left blank.
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
JUDITH FEINBERG, West Virginia University
JAMES HUGHES, Emory University
P. TODD KORTHUIS, Oregon Health & Science University
CHARLES P. O’BRIEN, University of Pennsylvania
SANDRA SPRINGER, Yale University
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by HUGH H. TILSON, University of North Carolina School of Public Health. He was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteur and the National Academies.
This page intentionally left blank.
Boxes and Figures
Patient Protection and Affordable Care Act
accountable care organization
Agency for Healthcare Research and Quality
American Society of Addiction Medicine
Centers for Disease Control and Prevention
clinical effectiveness research
Centers for Medicare & Medicaid Services
Conference on Retroviruses and Opportunistic Infections
Drug Overdose Prevention and Education
Drug User Health Initiative
hepatitis B virus
Healthcare Cost and Utilization Project
hepatitis C virus
Department of Health and Human Services
human immunodeficiency virus
Health Resources and Services Administration
incremental cost-effectiveness ratio
Infectious Diseases Society of America
Improving Addiction Care Team
medication(s) for addiction treatment (or therapy); medication-assisted therapy (or treatment)
medically enhanced residential treatment
medication for opioid use disorder
men who have sex with men
National Health and Nutrition Examination Survey
Nationwide Inpatient Sample
Naloxone prescription for Opioid Safety Evaluation
needle services program
opiate agonist therapy
HHS Office of HIV/AIDS and Infectious Disease Policy
Oregon Health & Science University
HHS Office on Women’s Health
Patient-Centered Outcomes Research Institute
prescription drug monitoring program
peripherally inserted central catheter
people who inject drugs
people who use drugs
rapid opioid dependence screen
Substance Abuse and Mental Health Services Administration
syringe exchange program
San Francisco Department of Public Health
syringe services program
substance use disorder
women who inject drugs
women who use drugs
|Buprenorphine||A partial opioid agonist|
|Naloxone||An opioid antagonist; the active ingredient in Narcan®|
|Naltrexone||An opioid antagonist|
|Suboxone®||Trade name for a combination of buprenorphine and naloxone|
|Vivitrol®||Trade name for an extended release form of naltrexone|
1 This text was revised after prepublication release.
This page intentionally left blank.